Cancer and Haematology
Karolinska Institutet is at the forefront of cancer research in the world. The primary goal of the research conducted at Karolinska Institutet is to make sure that as few people as possible suffer or die from cancer. Our research cover all areas, from the examination of molecules to the study of large demographic groups.
Cancer Research KI
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, that includes some 250 research groups. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
In depth articles and features
A golden age for a geneticist
A golden age for a geneticist
A diplomat with an interest in technology finds himself in the midst of the golden age of genetics. Richard Rosenquist Brandell’s goal is personalized treatment for all cancer patients.
She wants to prevent cancer
She wants to prevent cancer
In her research Elisabete Weiderpass focuses on identifying risk factors for cancer, with a particular focus on prevention and influence.
People should sunbathe more sensibly
People should sunbathe more sensibly
Yvonne Brandberg will always remember the young man struck down by cancer in the prime of life. His fate motivated her to try to convince more people to sunbathe more sensibly.
NK cell-based treatment for leukaemia
NK cell-based treatment for leukaemia
Naturel killer (NK) cells are a special type of white blood cell discovered at KI in the 1970s that can recognise and kill cancer cells. Researchers have now explored NK cell-based immunotherapy on patients with treatment-resistant leukaemia.
On the way to healthier lungs
On the way to healthier lungs
Lung cancer is the type of cancer that by far kills the largest number of Swedes every year. The main reason for the bad prognosis for the disease is that tumours are often discovered too late.
Spotlight on breast cancer
Spotlight on breast cancer
Between 15 and 20 Swedish women receive the diagnosis of breast cancer every day, making this the most common cancer among women. Read more about how scientists are working to reduce the mortality rates for this disease.
Spotlight on childhood cancer
Spotlight on childhood cancer
These days, the lives of many children diagnosed with cancer can be saved, but the treatment can lead to problems later in life. Researchers at KI are working to find better treatments for childhood cancers and to improve life quality for those who survive.
News about cancer and haematology
Some of our Professors in this area
Better treatment selection and outcome for cancer patients
Better treatment selection and outcome for cancer patients
Lennart Blomqvist researches cancer imaging, and has among other things helped to develop a method for the measurement of segmental liver function using MRI.
Less invasive treatments for oesophagus and stomach cancer
Less invasive treatments for oesophagus and stomach cancer
Magnus Nilsson conducts research on better treatments against cancer of the oesophagus and stomach. The objective is both to make the treatments more effective, and to make them less invasive.
Methods to distinguish different thyroid cancers
Methods to distinguish different thyroid cancers
Jan Zedenius is investigating cancer in the thyroid gland. He wants to understand the differences between various forms of the disease and how to detect these differences as early as possible.
Searching for future cancer therapies
Searching for future cancer therapies
Sonia Lain is searching for molecules that have the potential to become future cancer therapies. She is searching for substances that are effective against cancer cells but easier on healthy tissue.
“When you meet the patient the circle closes”
“When you meet the patient the circle closes”
Research breakthroughs are not just about new discoveries. Professor Anna Martling tells us how a long period spent on development meant that she was able to offer a patient life-saving treatment.
He wants to find the vulnerability in cancer
He wants to find the vulnerability in cancer
The continual division of cells in our bodies is pre-conditional to life; however, the process is a complex and delicate one and subject to serious error.
p53 – the guardian of the genome
p53 – the guardian of the genome
Sir David Lane discovered the protein p53 at the end of the 1970s. The protein's role is to discover and prevent genetic mutations that can lead to cancer.
Ways to enhance the immune system’s capacity to fight cancer
Ways to enhance the immune system’s capacity to fight cancer
Stephan Mielke research focuses on exploiting the potential of the patient’s own immune system to fight cancer as well as on improved methods for transplanting blood stem cells.